Shareholder Info

Share Price Information

ThromboGenics is listed on the Eurolist by Euronext Brussels under the symbol THR. 

As of 5 January 2018, ThromboGenics has a total number of 38,271,575 outstanding shares and a total number of 848,875 warrants.


View Shareholders History of Capital

Paying Agent Services

KBC Bank is acting as paying agent. The paying agent will not charge shareholders with respect to payments of dividends, the exercise of subscription rights, and other events concerning Thrombogenics’ shares. Shareholders should inform themselves about the amounts that other financial intermediaries may charge in connection with paying agency services.